Catherine Tralau-Stewart
Chief Tech/Sci/R&D Officer at VALIRX PLC
Profile
Catherine Jane Tralau-Stewart is currently the Chief Scientific Officer at ValiRx Plc and a Member of the British Pharmacological Society.
She was previously the Chief Scientific Officer at C4X Discovery Holdings Plc.
Tralau-Stewart received her undergraduate and doctorate degrees from UCL Medical School.
Catherine Tralau-Stewart active positions
| Companies | Position | Start |
|---|---|---|
| VALIRX PLC | Chief Tech/Sci/R&D Officer | 2022-09-07 |
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
Former positions of Catherine Tralau-Stewart
| Companies | Position | End |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 2023-01-09 |
Training of Catherine Tralau-Stewart
| UCL Medical School | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| VALIRX PLC | Health Technology |
| Private companies | 1 |
|---|---|
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
- Stock Market
- Insiders
- Catherine Tralau-Stewart
